| Financial Year |
March 31 2023 |
| Monetary Funds |
314,541,107.03 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
69,582,955.95 |
| Accounts Receivable |
304,412,511.61 |
| Advances to Suppliers |
58,075,475.47 |
| Other Receivables |
7,088,702.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
90,566,888.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
29,043,623.30 |
| Total Current Assets |
965,292,177.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
765,254,672.05 |
| Under-construction Projects |
212,666,797.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
131,741,981.23 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,479,073.97 |
| Deferred Income Tax Assets |
2,928,649.27 |
| Other Non-Current Assets |
55,657,999.49 |
| Sub-Total of Non-Current Assets |
1,219,156,184.22 |
| Total Assets |
2,184,448,361.96 |
| Short-Term Loans |
172,940,080.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
234,201,314.77 |
| Accounts Payable |
292,501,573.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,557,416.86 |
| Taxes Payable |
3,761,076.39 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
60,505,621.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
211,665,944.93 |
| Other Current Liabilities |
26,983,984.36 |
| Sub-Total of Current Liabilities |
1,061,733,524.95 |
| Long-term Loans |
119,820,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
74,155,965.92 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,210,179.35 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
218,369,095.56 |
| Total Liabilities |
1,280,102,620.51 |
| Paid-In Capital(Or Share Stock) |
184,966,135.00 |
| Capital Surplus |
887,753,361.09 |
| Surplus Reserve |
63,655,410.38 |
| LESS:Treasury Stock |
37,601,971.95 |
| Undistributed Profits |
-213,866,746.21 |
| Minority Stockholder's Interest |
19,439,553.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
884,906,188.31 |
| Owner's Equity（Stockholder's Equity） |
904,345,741.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,184,448,361.96 |
